Skip to content
#protein folding Open access

Benchmarking protein-ligand co-folding across Nav, Cav and Kv-family channels

Aug 2026 · Frontiers in Biophysics · 0 citations · 43 references
Receptor Mechanisms and Signaling

TL;DR

Results show that current co-folding methods remain unreliable as stand-alone predictors of ion-channel ligand-binding modes and highlight pose sampling, pocket selection, ligand representation and independent structural validation as priorities for methodological development.

Abstract

All-atom protein-ligand co-folding offers a route to modelling biomolecular complexes without prespecifying the receptor conformation or binding site, but its reliability for large, state-dependent membrane proteins remains uncertain. Here, we established a training-cut-off-aware benchmark of experimentally resolved ligand-bound complexes of voltage-gated sodium (Nav), calcium (Cav) and potassium (Kv) channels to evaluate AlphaFold 3, Boltz-2 and Protenix-v2 across multiple ligand representations. The final production set comprised 301 completed method-input jobs and 7,525 predicted structures generated from RCSB/CACTVS SMILES, Protein Data Bank Chemical Component Dictionary identifiers and matched PubChem and ChEMBL representations. Executable coverage differed markedly among methods, particularly for Kv-family systems, necessitating restriction of the balanced pose-accuracy comparison to 22 Nav and Cav complexes completed by all three methods. Median top-ranked ligand heavy-atom root-mean-square deviations were 19.85 Å for AlphaFold 3, 22.12 Å for Boltz-2 and 20.25 Å for Protenix-v2. Best-of-25 selection improved pose accuracy, but recovered a ligand pose within 5 Å of the experimental reference in only two, three and three systems, respectively, indicating that insufficient sampling was the predominant limitation, with ranking errors contributing to a smaller subset. Same-pocket recovery remained below 50% for all methods, despite broad preservation of receptor architecture, and method-native confidence measures showed limited discrimination of ligand-pose accuracy. Alternative ligand representations produced small aggregate changes but substantial system-specific effects on execution, pose category and ranking. Approximate close-contact screening identified additional geometric concerns in a subset of predictions. Collectively, these results show that current co-folding methods remain unreliable as stand-alone predictors of ion-channel ligand-binding modes and highlight pose sampling, pocket selection, ligand representation and independent structural validation as priorities for methodological development.

Read PDF

Similar papers

Open access Sep 2026

State-specific binding thermodynamics predicts ligand efficacy across ion-channel families

Predicting ligand efficacy is a critical challenge in drug discovery, as a target’s functional response is often determined by the way a ligand shifts conformational equilibria between different functional states, a process that is particularly intricate in ion channels. We classify ligands based on the difference of t...

Martin Vögele, A. Leffler, Kevin C. Felt et al. · 0 citations
#protein folding Open access Sep 2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

R. Gorantla, C. Schleberger, F. Sesterhenn · 0 citations
Open access Aug 2026

Benchmarking Docking Protocols for GPCR Allosteric Modulators

GaMD ensemble docking improved early AM enrichment across all four targets under at least one program, and the Boltz-2 deep-learning program showed minimal sensitivity to GaMD templates and underperformed conventional docking, suggesting its affinity predictions complement rather than replace physics- and empirical-bas...

T. D. Thompson, Ying-Long Miao · 0 citations
Open access Aug 2026

A Medicinal Chemistry-Centered Evaluation of AlphaFold 3 and Boltz-2 Across Diverse Binding Modalities

AlphaFold 3 (AF3) and Boltz-2 are state-of-the-art AI-based tools for biomolecular structure prediction, but whether their predictions provide useful guidance for lead optimization, SAR interpretation, and virtual screening remains insufficiently characterized. We benchmarked their performance using newly determined so...

Ke Chen, Zuo-Huang Qi, Omar Lozano Ramos et al. · 0 citations
#protein folding Open access Sep 2026

A curated benchmark for cofolding models on kinase conformational states

KinConfBench is introduced, a curated benchmark of 2225 high-quality human kinase chains to evaluate the ability of four state-of-the-art cofolding models—Boltz-2, Chai-1, Protenix, and RoseTTAFold-All-Atom—to recover both canonical and rare conformational states.

Kun-Yang Sun, T. Head-Gordon · 0 citations
Open access Sep 2026

Molecular docking versus co-folding for protein–peptide pose prediction: effects of protein flexibility and training set overlap

Synthetic peptides are increasingly important as therapeutic and diagnostic agents due to their high specificity, ease in synthesis, and suitability for targeting protein interfaces. However, accurate prediction of peptide binding poses remains a major challenge, particularly for conformationally flexible protein targe...

Mark Fonteyne, Nada Badr, P. Kuppen et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.